FDA Warning Letter: Supreme Rejuvenation, LLC
type: Action
additional type: https://schema.org/RegulationAction
start time: 2025-05-20
description: Unapproved New Drugs/Misbranded. Issued by FDA Center for Biologics Evaluation and Research on 2025-05-05.
agent: FDA Center for Biologics Evaluation and Research
object: Supreme Rejuvenation, LLC
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
source organization: U.S. Food and Drug Administration
publisher: AI Analytics

PropertyValue
property ID: FDA Warning Letter ID
value: 8a957e0be17c1e1e

AI Analytics
type: Organization